• In June 2023, FUJIFILM Irvine Scientific, Inc. expanded its Presagen’s Life Whisperer platform capabilities to help with clinical decision-making in IVF.

• In May 2023, Merck KGaA introduced Fertility Counts to address societal, economic, and social challenges associated with low birth rates in the Asia Pacific (APAC) region.

• In May 2023, Ovation Fertility combined with US Fertility to created fertility platform offering advanced fertility care and IVF services in the U.S.

• In April 2023, Boston IVF signed 3 years supply chain solutions agreement with Cryoport, Inc. to support the reproductive material shipment across the U.S.

In this report, the Global In Vitro Fertilization (IVF) Market has been segmented by Instrument, Procedure, Type, End Use, and Geography.

Global In Vitro Fertilization (IVF) Market, Segmentation by Instrument

The Global In Vitro Fertilization (IVF) Market has been segmented by Instrument into Capital Equipment, Culture Media, and IVF Disposable Devices.

The Capital Equipment segment forms a crucial backbone of the global IVF market, contributing nearly 35% of the total revenue. This category includes sophisticated machinery such as incubators, micromanipulation systems, and laser systems, which are driving increased efficiency in IVF procedures. With a growing emphasis on automation and miniaturization, demand for these advanced devices continues to rise.

The Culture Media segment accounts for about 30% of the IVF market worldwide, playing a vital role in supporting embryo growth and viability. Continuous innovation in media formulations has significantly improved embryo development outcomes, making culture media indispensable in modern IVF treatments. The rise in successful implantation rates is largely attributed to advancements in this segment.

The IVF Disposable Devices segment captures around 25% of the global IVF market share, fueled by the need for sterile and single-use products. This category includes essential items like pipettes, needles, and catheters, which ensure safety and prevent contamination during procedures. The growing volume of IVF treatments globally is boosting demand for these disposable solutions.

Global In Vitro Fertilization (IVF) Market, Segmentation by Procedure

The Global In Vitro Fertilization (IVF) Market has been segmented by Procedure into Conventional IVF, IVF with ICSI, Minimal IVF, IVF with Donor Eggs and Others.

The Conventional IVF segment makes up nearly 30% of the global IVF market. This method involves the fertilization of eggs and sperm in a controlled laboratory setting without advanced micromanipulation. It remains a widely practiced and trusted fertility treatment in clinics around the world.

The IVF with ICSI segment commands about 40% of the global market, offering a highly effective solution for male infertility. By injecting a single sperm directly into an egg, ICSI significantly improves fertilization rates. Its effectiveness has driven its widespread use in modern fertility treatments.

The Minimal IVF segment, contributing nearly 10% of the IVF market, emphasizes reduced hormonal stimulation and fewer egg retrievals. This gentle, cost-effective approach minimizes side effects and aligns with patients seeking a more natural IVF experience.

The IVF with Donor Eggs segment accounts for approximately 15% of the market. This option is crucial for women with diminished ovarian reserve, advanced maternal age, or genetic considerations, providing a reliable alternative for achieving pregnancy.

The Others segment represents about 5% of the global IVF market. It encompasses innovative and evolving fertility techniques beyond conventional protocols. This category is expanding as technology advances and new assisted reproduction methods emerge.

Global In Vitro Fertilization (IVF) Market, Segmentation by Type

The Global In Vitro Fertilization (IVF) Market has been segmented by Type into Fresh Donor, Fresh Nondonor, Frozen Donor, and Frozen Nondonor.

The Fresh Donor segment contributes approximately 20% to the global IVF market. This method uses freshly retrieved donor eggs, which are immediately fertilized and transferred. It is known for its high success rates but requires precise coordination of donor and recipient cycles for optimal outcomes.

The Fresh Nondonor segment makes up about 40% of the total IVF market, involving the use of a woman’s own fresh eggs for fertilization. This approach is popular for its immediate embryo transfer capability and high implantation potential, making it a top choice in IVF clinics.

The Frozen Donor segment represents nearly 15% of the IVF market. This method leverages frozen donor eggs, offering flexibility and eliminating the need for cycle synchronization with the recipient. It’s increasingly preferred for its convenience and comparable success rates to fresh cycles.

The Frozen Nondonor segment captures approximately 25% of the global IVF market. This approach involves using a woman’s own previously frozen eggs or embryos, providing the benefits of better cycle planning, reduced hormonal burden, and consistent success rates with fresh IVF procedures.

Global In Vitro Fertilization (IVF) Market, Segmentation by End Use

The Global In Vitro Fertilization (IVF) Market has been segmented by End Use into Fertility Clinics, and Hospitals.

The Fertility Clinics segment leads the global IVF market, accounting for around 70% of total revenue. These specialized centers offer advanced assisted reproductive technologies and personalized care, contributing to higher success rates. The growing prevalence of fertility challenges and awareness about treatment options continue to fuel the dominance of this segment.

The Hospitals segment makes up approximately 30% of the IVF market. Hospitals are increasingly incorporating fertility services into their broader healthcare offerings, especially in areas with limited access to dedicated fertility clinics. This integration is driving steady growth in the hospital-based IVF segment.

Global In Vitro Fertilization (IVF) Market, Segmentation by Geography

In this report, the Global In Vitro Fertilization (IVF) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global In Vitro Fertilization (IVF) Market Share (%), by Geographical Region, 2024

North America commands a significant 35% share of the global IVF market. This dominance is attributed to well-established healthcare systems, increasing infertility rates, and supportive insurance policies, particularly in the United States and Canada, driving strong demand for advanced fertility treatments.

Europe contributes around 30% to the global IVF market, thanks to comprehensive regulatory frameworks and widespread awareness of assisted reproductive technologies. Supportive reimbursement schemes and access to cutting-edge IVF services continue to propel market growth in this region.

The Asia Pacific region holds approximately 20% of the IVF market. Rising infertility rates, expanding medical tourism, and growing numbers of fertility clinics in major countries like China, India, and Japan are key factors driving market expansion.

Middle East and Africa capture about 10% of the global IVF market. Cultural acceptance of fertility treatments is growing, and improvements in healthcare access, particularly in the UAE and South Africa, are contributing to rising demand for IVF procedures.

Latin America accounts for nearly 5% of the IVF market share. The region is witnessing growth in IVF adoption, particularly in Brazil and Argentina, where increased awareness and investment in fertility services are enhancing market prospects.

This report provides an in depth analysis of various factors that impact the dynamics of Global In Vitro Fertilization (IVF) Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Advancements in Assisted Reproductive Technologies
• Increasing Infertility Rates
• Growing Demand for Parenthood Delayed Due to Career and Lifestyle Factors

• Expanding Access to IVF Services - Expanding access to IVF services is a key driver of growth in the global in vitro fertilization (IVF) market, fueled by rising awareness, improved affordability, and advancements in fertility care infrastructure. Governments and private healthcare providers are increasingly investing in IVF clinics, public funding programs, and reimbursement policies to make treatment more accessible. This expansion is particularly notable in emerging economies, where demand for reproductive services is rising among urban populations.

  The proliferation of telemedicine platforms and cross-border fertility services has also helped patients overcome geographic and social barriers to access. As a result, more individuals and couples are opting for IVF as a viable solution for infertility, boosting procedural volumes worldwide. This broader access is expected to continue driving sustained growth and technological innovation in the IVF market.

Restraints

• High Cost of IVF Treatment
• Ethical and Legal Concerns
• Emotional and Psychological Stress Associated with IVF

• Risk of Multiple Pregnancies and Birth Defects - The risk of multiple pregnancies and birth defects remains a significant restraint in the global in vitro fertilization (IVF) market. The transfer of multiple embryos during IVF cycles, often done to increase success rates, can result in twins or higher-order births, which are associated with complications such as preterm delivery, low birth weight, and increased neonatal care needs. These outcomes raise concerns among healthcare providers and patients, affecting their willingness to pursue or recommend IVF treatments.

  Additionally, studies have linked assisted reproductive technologies to a slightly elevated risk of certain congenital anomalies, especially in cases involving older maternal age or underlying infertility conditions. Although the overall risk remains low, it prompts increased regulatory scrutiny and the need for more extensive patient counseling. These concerns may hinder broader market adoption, particularly in regions with less advanced clinical oversight or limited public awareness.

Opportunities

• Technological Advancements in IVF Techniques
• Growing Acceptance of Third-Party Reproduction
• Expansion of Fertility Tourism

• Rising Demand for Egg Freezing and Social Egg Freezing - The rising demand for egg freezing and social egg freezing presents a significant opportunity for growth in the global in vitro fertilization (IVF) market. As more women choose to delay childbirth for personal, educational, or professional reasons, social egg freezing has emerged as a proactive reproductive option. This trend is being driven by increased awareness, improved success rates, and greater societal acceptance of fertility preservation technologies.

  Clinics and IVF centers are expanding their offerings to include elective egg freezing packages that cater to younger, healthier women who want to preserve their fertility for future use. Unlike medically indicated freezing, which is used for patients undergoing treatments like chemotherapy, social egg freezing is elective, creating a broader, non-clinical consumer base. This shift is expanding the market beyond traditional infertility cases and into the domain of reproductive planning and lifestyle choices.

  Technological advances in vitrification techniques have made egg freezing more reliable, with higher survival rates and successful thawing outcomes. As a result, both short-term adoption and long-term retrievals are increasing, positioning fertility clinics for repeat patient engagement. Additionally, rising investments by private players and insurers in fertility benefits are making the process more accessible to a wider population.

Key players in Global In Vitro Fertilization (IVF) Market include :

• OvaScience
• Vitrolife
• EMD Serono
• Irvine Scientific
• The Cooper Companies
• Cook Medical
• Thermo Fisher Scientific
• Genea Biomedx
• Progyny
• Boston IVF

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Market Share Analysis
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis